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Cyt:okines are believed to play an important role in 
the pathogenesis of cutaneous T cell lymphoma. 
Data regarding the local cytokine pattern in mycosis 
fungoides (MF) are partly conflicting. Recent studies 
have suggested a shift from type 1 to type 2 cytokine 
pattern because IL-4 and IL-5 mRNA have beenlnore 
frequently detected in lesions of advanced stages. 
Another study has described a type 1 cytokine pattern 
in MF lesions. None of the previous studies of cyto-
kine l:DRNA expression in MF, however, used quan-
titative methods, and therefore only the presence of a 
cytokine, but not the level of expression, could be 
determined. To gain better insight into the develop-
ment of cytokine pattern during tumor progression 
we used semiquantitative reverse transcriptase-poly-
merase chain reaction to analyze cytokine mRNA 
expression in MF skin lesions at different stages. 
Biopsies from patients with patch (n = 11), plaque 
(n = 6), and tumor (n = 3) stage MF were compared 
I n 1986 Mosmann and colleagues reported that CD4 + T cells in mi ce can be classified in to two subgroups with regard to their cytokine Produc.tion pattern and the re lated functional activities, i. e., T helper 1 (Thl) and T helper 2 (Th2) cells (Mosmann ct nl, 1986). Thl and Th2 cells are 
noW d efined by their predominant production of [L-2Iinterferon-y 
(IFN -}') / tumor necrosis factor- /3 or IL-4/ IL-5 / [L-6/ IL-1 O/IL-13, 
respectively, and because not only CD4 -I- Th cells contribute to the 
cytokine response, the cytokine patte rns are often classifIed as type 
1 or type 2. Although this model has provided a va luable frame-
work for investigation of many immune reactions, recent studies 
bave d emonstrated a remarkable diversity in cytokine profiles. 
suggesting a continuous spectrum in which the classic type 1 and 
type 2 pattems represent extremes (reviewed by Kelso, 1995). 
T his diversity is also reflected in several dermatoses . For exam-
with biopsies from patients with pleomorphic T cell 
lymphoma (n = 5), psoriasis (n = 7), atopic dermatitis 
(n = 5), and nonlesional skin (n = 8). MF progression 
was associated with significantly higher IL-IO and 
lower interferon-y n1.RNA expression. Moreover, the 
stage-dependent increase in IL-IO mRNA expression 
was also found in paired san1.ples from individual 
patients. Unlike in pleomorphic T cell lynJ.phoma, 
however, typical T helper 2 cells did not seem to be 
the source of increasing IL- IO in advanced MF, be-
cause stage-independent IL-4 mRNA was rarely de-
tected, suggesting contribution of nonlymphoid cells 
to local IL-IO production. The overexpression of 
IL-IO in MF may be of importance for tumor progres-
sion, because this ilnmunosuppressive cytokine 
might be involved in downregulation of hnlnuno-
logic tumor surveillance. Key IIlovds: CjltokilleslCTCLI 
IFN-yITII1IT"2. ] Invest Dev",atol107:833-837, 1996 
cytokine profile that is different fr0111 both types 1 and 2 (Vollmer 
rt nl, 1994). [n atopic dermati tis. rL-:LO (type 2) overexpression is 
accompanied by IFN-')' expression (type 1), w hereas LL-4, a type 2 
cytokine, is barely detectable (Ohmen el nl, 1995), T hese findings 
illustrate the need for more extensive studies of cytokine expression 
using quantitative methods in order to characterize th e cytokine 
patte rns of dermatoses and better understand the pathophysiologic 
mechanisms. 
ple, psoriasis, initially thought to be characterized by a typical type 
I 1 patten, (Uyemura et nl, 1993; Schlaak et nl, 1994), exhibits a 
Cytokines are considered to be of major impo rtance for the 
pathogenesis of cutaneous T-cell lymphoma (CTCL) (Hsu ct nl. 
1993; Rook eI nl, 1993; Burg ct nl, J 995). Several cytokines have 
been detected in mycosis fungoides (MF) skin les ions (Tron l'f nl, 
1988; Lawlor e/ nl, 1990; Wismer el nl, 1994; Sarris ef nl, 1995). Saed 
ct nt (1994) reported that p laque stage MF was characterized by a 
type 1 cytokine profil e, whereas Vowels et nl (1994) , who investi-
gated patch, plaque. and tU1110r stage MF, also detected IL-4 alld 
rL-5 mRN A in some plaque stage and all tumor stage biopsies and 
therefore suggested a stage-dependent shitt fr0111 the typc 1 to type 
2 in MF progress ion. T his discrepancy may result, at least partially, 
fi'om difFerences in sensitivity of the reverse transcriptase-poly-
\l1crase chain reaction (RT-PCR) methods used (Lessin e( nl, J 995; 
Saed el nl , 1995). Moreover. the use of qualitative. rather t.han 
quantitative, RT -PCR techniques has limited all cytokine gen e 
express ion studies in MF and other dermatoses. 
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tion. It favors the development of a type 2 cytokine pattem by 
inhibiting th e IFN-y production by T cell s and natural k iller ce ll s 
via suppression ofIL-12 synthesis in acccsso l'y ce ll s (D'Andrea e/ ai, 
1993) . Moreover, it suppresses proinAammatory cytokine produc-
tion and redu ces antigen-presenting capacity of monocytes/macro-
phagcs (De Waal Malefyt el ai, 1991; Fioren t ino e/ ai, 1991a, b). 
T h erefore, if e nhaJlced IL - IO e;-''}Jression werc prescnt in th e course of 
MF, it might contribu te to th e inhibition of an adequate anti-tumor 
response. So fa r , however , TL- l0 transcripts h ave been sou g h t in 
plaque lesions of MF but h ave not been detected (Saed el ai, 1994). 
T h e objective of thi s study was to further c haracterize t h e type 
112 cytokine pattern in CTCL using a semiquantitative R.T -PCR 
technique. We studied the expression of IL-l 0, I FN-y, and IL-4 in 
patch , plaquc, and tu m or stage biopsies of MF patients including 
paired samples from sin g le patients w it h skin les ions fi 'om different 
stages of the d isorder. We demonstrate that the progression ofMF 
is associated w i th in creasin g IL-10 and decreasing IFN-y mRN A 
expression . Since, unlike IL -1 0 mRNA, lL-4 mRNA was o nl y 
rare ly detected, however, o ur results do not g ive sufficient evidence 
for the deve lopment of a classic type 2 cytokine pattern during MF 
progression. 
MATEIUALS AND METHODS 
Patients Skin punch biopsies (4 to 8 mm) were obtaincd fi:om adult 
patients with un treated CTCL (n = 11), psoria sis (n = 7), or atopic eczema 
(n = 5). Thc biopsy was divided and the diagnosis was confirmed by 
histo lof,'Y' In five of the 11 CTCL paticnts, diagnos is was further supported 
by the detcction of monoclona l T-cell exp:msion using PC R techniquc. T he 
material obtained from the CTCL patients cons isted of sam ples from patch 
(n = 11), plaque (n = 6), tumor (n = 3) stage MF, and from pleomorphic 
T-cell lymphoma (n = 5) as determined by clinica l and histo logic criteria 
(Stcrry, 1985). In eight patients (two MF, thrce psoriasis, thrce atopic 
dermatitis) , an additional biopsy was obtained fi'om apparently nonlesional 
(healthy) skin. T h e study was approved by our Institutional Review Board. 
and informed consen t was obtained from all patients. 
RNA Preparation and Reverse Transcription Tota l R.N A was pre-
pared from small tissuc samples as dcscribed elsewhere (Pla tzcr ct ai, 1994). 
BrieRy, tissue specimens were snap-&ozCli in 500 fJ.1 of gu:midiniull1 
isothiocyanate solu tion (Chomczynski and Sacchi. 1987) and homogenized 
with a dispersing system (Ultra Turrax, J anke and Kunkel, Staufen, 
Germany) duriug thawing. Five hundred m icro li te rs of water-saturated 
phenol, 100 fJ.1 of chloroform:isoamyl alcohol (24:1 vol/vol), and 50 fJ.I of 
sodium acetate (2 M, pH 4) were added to the lysate. Mixtures were 
vortexed and stored 0 11 icc for a furthcr 10 min prior to centrifugation 
(1000 X g. 20 min, 4°C). The aqueous phase was incubated with 8 fJ.1 of 
matrix (J~aid PLUS Kit, Dianova, Hamburg, Germany) at room temper-
ature for 5 min and then centrifuged (1000 X g, 1 min) . The RNA-bonded 
m atrix was washed three times with l~A wash so lu tion (Rnaid PLUS Kit), 
and tota ll~A was elu ted with 10 - 20 fJ.1 of diethyl pyrocarbollate-treated 
water. T he quali ty of tota l RNA was estimated by electrophoresis on 
ethidiull1 bromide-sta ined l'lI. agarose gel. mR.NA was reverse transcribed 
in to complementary DNA (eDNA) using oljgo-dT primers (Murphy "I ai, 
1993) in 40-fJ.1 reaction mixtures containing about 0.2 fJ.g to 1 fJ.g of tota l 
l~A. 
RT-PCR Amplification and Primers Competitive PC R was intro-
duccd in 1989 (Wang el ai, 1989) and was performed as we described in 
detai l elsewhere (Platzer "I nl, 1994; Sicgling <I "I, 1994) . In our method a 
competitor control &agment is used together with sample cDNA in the 
reaction mixture . Sample and contro l cDNA are amplified with the same 
prinlers. and variations in anlpLifi catio ll citic icncy between reactions can be 
cstinlatcd because the control fragl11cn t serves as an internal control. T he 
control and sample PCR products arc distinguished on gel electrophoresis 
by diffcre nces in length . With the inpu t concentration of the comrol 
fragme nt being known and ampli fication of both VCR products occurring 
proportiona ll y, it is possible to quantify the salllple cDNA. A cDNA 
equiva lent of about 5 ng of tota l RNA was taken for each R T-PCR ana lysis. 
For som e add itiona l ana lyscs a eDNA equi va lcnt of up to 25 ng of tota l 
RNA was taken . The fo llowing oligonucleotides were uscd as primer pairs 
(sense/anti-sense) : GADPI-I, GCAGGGGGGAGCCAAAAGGG/TGCCA-
GCCCCAGCGTCAAAG; IL-4, GCTTCCCCCTCTGITCITCC/TCT-
GGTTGGCTTCCTTCACA; IFN- y. TCGTTTTGGGTTCTCTTGGCI 
GCAGGCAGGACAACCATTAC; IL-1 0, CTGAGAACCAAGACCCAG-
ACATCAAGGI AATAAGGTTTCTCA.AGGGGCTGG (PI:ltzer el nl, 
1994) . In order to equilibrate the input cDNA ;lIllounts of the samples 
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Figure 1. Progression of MF is associated with increasing IL-IO 
mRNA expression in skin lesions . IL-10 mP. .. NA expression was ana-
lyzed in biopsies from patien ts with patch (n = 11), plaquc (n = 6), Or 
tumor (n = 3) stage MF and in biopsies li'om patients with psoriasis (n = 7) 
and atopic de rmatitis (n = 5). Moreover. nonles ional (healthy) skin samples 
of eight patients (two MF, three psoriasis, three atop ic dermatitis) were 
an:!Iyzed. l~A preparation, reverse tra nscrip tion, and semiquantitative 
I<. T-PCI<. were carried o ut as described in Mnleria ls n",1 Melhods to determine 
I L-10 gene expression. The concentrations were expressed in AUs. One AU 
was deflncd as the lowest concentration of control fTagment that yielded a 
detectable ampJjfication product g iven the parti cular primer pair and PCR 
conditions used (Platzer " I nl, 1994). Data are shown as mean :t SEM. lL-l O 
mRNA was detected in almost all skin biopsies. T he mean va lue of lL- l O 
ml~A expression in the more advanced stages of MF (p laque and mOlar 
stage) was significantly higher than in patch sta ge MF (p < 0.05; Mann-
Whitney test) and psoriatic or non les ional skin (I' < 0.01; Malln-Wbitney 
tcst) . 
studied, we first determined the concentration of the house-keeping gene 
g lyceraldehyde-3-phosphate deh ydrogenase (GAPDH) m R.NA using com-
petitive It T-l'CR and GAI'DH-spccific primers. After adjusting aU samples 
to equa l GAPDH-cDNA concentration, the relative cytokine cDNA 
amount was determincd in a second competitivc RT-PCR using tile 
appropriate cytokine-specifi c primers. The re lative concentration of tile 
cytokinc cDNA in each sample was expressed in arbitrary units (AU). One 
AU was defined as the lowest concentration of control fragment that 
yielded a detectable amplification product given the particular primer pair 
and PCI<. conditions used (Platzer el nl, 1994). Control RT-PCR. WitllOut 
template DNA was performed in all experiments to exclude contamination. 
As an additio nal contro l, the R T -PC I~ reaction was performed as described. 
but R T was omi tted in the reaction mixtm e for each specimen in order to 
distinguish the amplific:ltion of contam inating genomic DNA &om that of 
reversely tra nscribed mRNA. In order to increase sensitivity, RT-PCR 
without contro l fi'agments and high amounts of cON A stock solutions 
(equivalent of 25 Ilg of total RNA) were performed in some experiments . 
Statistical Analysis Data are presented as mean :!: SEM. Statistical 
ana lysis included the chi-square assay for frequencies , the Mann-Whime)' 
test for the comparison of groups, and the W i.lcoxon test for paired samples . 
An error probability (1') lower than 5% was considered significant. 
RESULTS 
IL-l0 nlRNA Overexpression in MF Is Stage-Dependent 
IL-10 mR.NA was detected in almost a ll skin samples . High levels 
of IL-10 mRNA were detected in skin from patie nts with atopic 
dermatitis and CTCL in contrast to healthy and psoriatic skin. 
Inte restin g ly, the c ll taneou s IL-l 0 gen e expression in MF was 
stage-depe ndent; levels oflL-1 0 mRNA expressio n increased along 
with disease progression £i'om patch to plaquc and from plaque to 
tumor stage (Fig 1). W h en comparing th e lL-1 0 transcription 
levcls of patch stage MF (n = 11; mean :t SEM: 76 ± 22 AU) with 
that of more a d vanced stages (p laq u e 'lIld tumor; n = 9; 188 ± 39.6 
AU), we fOllnd a significan t difference (p < 0 .03; Mann- W hiOley 
test). l L-1 0 mRNA express io n in advanced stages of MF as well as 
that in atop ic dermatitis was significantly hi g h e r than in psoriatic 
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Figure 2. IL-10 gene expression in paired samples from MF pa-
tients . lL-l 0 mllNA expression was analyzed in paired skjn biopsies of 
different stage lesions ill fiv e patients (Pt 1-5) wi th MF as described in Fig 
1. T h e IL-l0 I11KN A concentration in patch stage was significantly lower 
than in plaque stage MF (p < 0.05; Wil ox on test). 
and nonlesional skin (p < 0.01). No signifi cant di ffe rences w ere 
detect e d be tween p<ltch stage M F, pSOI'iatic, and nonlesional skin . 
In fiv e MF patients, paired biopsies from lesion al skin of different 
stages w en:! collec tcd at the same timc . In all fiv e patients an 
incr ease in LL-I0 mRN A express io n fi'om patch to plaque stage was 
demonstrated (Fig 2); it w as significantly highe r in pl<lque stage 
lesions compared to patch lesions (p < 0.05 ; Wilcoxon test) . 
M o reo v er, an furth er increase o f IL- I O mIlN A expression w as 
detect e d in the pati ents in whom additional tumor stage biopsies 
had b een analyzed (Fig 2) . Figure 3 sho w s IL-1 0 mllNA expres-
sion in p aired samples from a sing le patient. Also , in patients wi th 





Figure 3. Higher IL-10 mRNA expression in tllmor stage lesiotl 
than in patch stage lesion in MF. IL- l0 mRNA expression was analyzcd 
in b io p s i es &0 111 a sing le pati e n t wi th patch ;"Iud tUln o r stage M F les io n s as 
describe d in Fig 1. T he trialls les li t tile l"' tWIII indica te the dilu tion of the 
contro l fragment DN A (cf) : fi-Oln IrJi til ris ht. 900 AU. 300 AU. 100 AU. T he 
"pper a l1d th" I""' fr ballds represent the cDNA and the control fragmcnt 
amplifica tion products. respectivel y. M. molecular weight markers. Ln(Il' I 
alld 5, "'ater blan ks (negative control); IIIII CS 2- 4. patch stage sample with 
different cf dilutions; lalles 6- 8. tumor stage sample with different control 
fragm e n t dilutions. The equimolari ty between control f'i-agl11 ent and sample 
was rea c h ed in the pa tch and tumor stage sample at cf dilu tions of about 100 
AU and 300 AU. respectively. The video imaging analysis showcd a 
2.6-fo ld higher I L- I a level in the tumor stage sample than in the patch stage 
sample. 
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Figure 4. Progression of MF is associated with decreasing IFN-y 
mRNA expression in skill lesions. IFN-y mRNA expression was 
analyzed in biopsies from patients with patch. plaque. and tumor stage M F 
and nonlesional skin as described in Fig 1. Data arc shown as mean :!:: SEM. 
The II11",bers i" Ih l' "1'1'''1' part of the fi gure indicat.e the fi'eq uency of IFN-y 
mLlNA detection. T he frequency of IFN-y detection was signi fi cantly 
higher in patch stage MF than in more advanced stages (wmor and plaque; 
p < 0.05; chi-square assay) as well as in nonlesional skin (p < 0.0 I . 
chi-square assay). 
higher in nodular lesions (n = 3; 810 :!:: 387 A U) than in patch 
lesions (n = 2; 22 0 ::':: 199 A U) (n o t shown) . 
MF Progression Is Associated with Decreasing IFN-,), 
mRNA Expression In contrast to IL-1 0, IFN-y mRNA w as 
de tected in only a few M F sampl es and no t in uninvolved skin. 
Inte restin gly, a decrease in lFN-y m.IlNA expressio n fr0 111 patch to 
p laque and fi'om plaque to tumor stagc was o bserved (Fig 4). 
IFN-y mRNA was de tec ted m ore fj'cquently in patch stage (seven 
of 11) than in the m ore advan ced plaque and tUlllo r stages (two of 
nine) of M F (p < 0.05 ; ch i square assay) o r nonlesional skin (zero 
of eight; p < 0.01, chi squarc assay). Moreover, the m ean va lue ~f 
IFN-y mRNA expression w as about 2 times higher in p atch M F 
than in ~l aque MF. The stage dependcn cy in paired samples from 
each p atient was n o t as strong as fo r fL-J a (no t shown) . In patien ts 
w ith pleom orphic T - celllymphom 3, IFN-y mRN A cxpression was 
highe r in patch lcsions (n = 2; 500 ::':: 501 AU) t1mn in n odular 
lesions (n = 3; 253 ± 129 AU) (not shown ). 
IL-4 mRNA Is Rarely Found in MF T he stage-dependent 
in verse regul ation of lL-IO and IFN-y gene c xprcss io n in M F skin 
suggested a shift fi'om a type 1 to a typ e 2 cyto kin e pattern with 
progress ion o f the disease . If the c:\:p ansion and / or increased 
activation ofTh2 cclls was responsible fo r in creasing IL-I 0 expres-
sion , IL-4 tran scripts should be uprcgulated concomitantly . 
Surprisingly, IL-4 mR.NA w as only rarely de tected. Positive 
results w ere obtained in ollly on e bi o psy, which w as fro m a pati ent 
w ith patch stage MF, but all samples o f nodular pleomorphic T - cell 
lym phom a and t11ree of fi ve bio psies fro m patients with ato pi c 
dermati tis contained IL-4 mRN A (Ta ble I) . T he high es t levels of 
IL-4 rnRN A w ere detected in the nodul ar skin lcsions from t1H! 
patients with pl com orphic T - cell lymphoma. No significant diffcr-
ences be tween the g roups w ere o bse rved in the fi'cquency of 
dc tection and the level of expression . T hc fi'cqu cncy o f lL- 4 
de tection in our sampl es did not increase w hen w e used higher 
input cDN A am o unts for thc R T -PC R. analysis (sec Materials Qll d 
M eth ods) . 
DISCUSS IO N 
IL-IO mR.NA was de tected in all stages of MF. W e found 
in creasing levels o f IL-1 a mRNA expression , howevcr, fro m pa tch 
to plaque and fi'om plaque to tumor scage M F. Inte res tingly, this 
stage-dependent increase of IL-I O m.IlNA express ion was also 
o bscrved in paired samples from individual patients. These data 
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Table I. IL-4 Is Rarely Detectable in MF Skill Samples" 
IL-4 mRNA leve l (AU) 
Frequency of 
IL-4 Detection Median Range 
Mycosis fungoides 
Patch stage 1/11 0 0-28 
Plaque stage 0/6 0 0 
T umor st.1ge 0/3 0 0 
Pleomorphic T cell lymphoma 
Patch-like 012 0 0 
Nodular 3/3 63 45- 82 
Psoriasis 0/7 0 0 
Atopic dermatitis 3/5 19 0-36 
N onlesional skin 0/8 0 0 
" IL-4 ml"tNA express ion W:lS analyzed ill skin bio psies. RNA prepara tio n , reverse 
transcription, :md se miqu antirative itT-pe R. were carried Ollt as described ill lV/a leria's 
aflll A4ellwds to determine lL-4 gene ex pression. O ne arbitrary lInit (AU) W::IS defined 
as the lo west concentration o r contro l fra gment that yielded a detectable ampii tication 
product given the particular primer pair ,lI1d PC R condirio ll s lI sed (Platzer t:f (/ / , '1994) . 
support the advantage of semiquantitative m ethods. Conversely, 
IFN-y gene expression decreased w ith progression of MF. Similar 
findings regarding IL-10 andIFN-")I express ion were observed in 
pleomorphic T-cell lymphoma. 
Thus far, these findin gs support the hypothesis that the progres-
sion of CTCL is associated with a switch from type 1 to type 2 
cytokin e patte rn as suggested by others (Vowels el ai, 1994 ; Less in 
e/ "I, 1995). While Saed el al (1 994, 1995) ini tially presumed that 
MF exhibits a type 1 cytokine pattern , Vowels cl al (1994) 
speculated that tumor cells in CTCL principa lly express the T h2 
type and that th e switch in th e skin cytokine pattern results from an 
alte red cell patte rn during progression: in early stage MF, when 
onl y few tumor cells are de tectable in the in fi lt rates, the cytokine 
profile is dominated by type 1 cytokine- express in g reactive T ce ll s, 
w hereas in advanced lesions type 2 malignant ce lls replace the 
reactive T - cell infutrates. Unlike Vowels' el. ai , however, we rare ly 
detected IL-4 mRNA. T hi s co uld be the result of a lower sensitivity 
of our IL-4 test system. T he sensitivity of our quantitative RT -PCR 
m ethod, however, was sufficiently high to de tect about 10 -20 IL-4 
mRN A mol ecules per PCR tube (Platzer el ai, 1994). In agreem ent 
with this re latively hjgh sensitivity , w e detected IL- 4 mRNA in skin 
fi·om nodular pleom orphic T - cell lymphoma an d atopic dermatiti s 
(Table I) . Moreover, IL- 4 mRNA was eas ily detected in sm alJ 
kidn ey core biopsy spec imens fi:o t11 transplant patients with acute 
rejection even th ough only 10-20% of gra ft ce lls be longed to the 
T - cell lineage (Ode-Hakim el ai , 1996) . T his indicates that our tes t 
system is suitable for detection of IL-4 mRNA. T here fore, it was 
certa inly suffic iently sensitive to exclude high level JL-4 gene 
express ion in o ur: samples 6·om advanced stages of MF. 
T he apparent absence of significant lL-4 mRNA expression 
argues against typical T h2 cell s as the source of the abundant IL-l 0 
expression, which reached > 1000 IL-IO cDNA m olecules per 5 ng 
total RN.A in advanced MF. R ecently, a novel T h ce lJ subtype w as 
described that secretes TGF-/3 and IL-10 but not IL-4 and IL- 5 or 
IFN-y and IL-2. T lLis T h subset is found partiCLuarly in the 
mucosa-associated lymphoid tissue and supports IgA syn thesis (P. 
M atz inger, personal communicatio n) . We found a similar pheno-
type in kidney biopsies from patients with chronic rej ection (Ode-
Hakim e/ ai, in press) . T he maljgnant ce ll in MF may also belong to 
this newly discovered T h phenotype . Expansion of these cells 
during tumor progress ion would ex plain increasing IL-I 0 expres-
sion in skin les ions. In terestin gly, several other human tumors 
spontaneously secrete IL-10 , thus downregu lating the anti-tumor 
response (Pi sa el al. 1992; Gastl el ai, 1993; Llischer el ai, 1994). In 
addi tion to T ce IJ s (reactive o r malignant), h owever, monocytes/ 
maCrOpll<lges and/or keratinocytes m ay also be responsible for 
increasing IL-IO gene expression in advanced MF, because these 
cells are also able to produce IL-1 0 afte r activation (Fiorentino el ai, 
1991 a, b; Nicko loff and T urka , 1994; Enk el ai, 1995). It is poss ible 
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that as a resul t of the chronic inflammation in MF skin, IL-10 is 
overexpressed by ke ratin ocytes. In this model. the malignant cells 
do not contribu te, o r contribute only marginally, to the local 
cytokinc patte rn. Further studies using ;1/. s;11I techniques are 
necessary to determine the cellular source of IL-1 0 and other 
cytokin es de tectabl e in MF skin. 
W e w ere able to confi rm an associatio n between tumor progres-
sion and a shift in the cytokine pattern , w hich migh t be involved in 
the pathogenesis of CTCL. Since IL-1 0 downregulates T hl and 
cytotoxic T-cell fun ction as well as dermal m acrophage activi ty 
(Fio rentino el ai, 1991a, b; Matsuda el ai, 1994), this may result in 
the loss of control of the tumor by the immune system and 
progression of the tumor. An increasing number of advan ced stage 
les ions in MF patients may result in sys temic effects of locally 
produced IL-I0, inducing global cytokine imbalance. T he devel-
opment of a systemic type 2-like cytokine pattern would explain 
the immunobio logic alterations occurring during CTCL progres-
sion. In the earl y stages, th e immune response is usually unaltered. 
High level expression of IL-4 and IL-5 might exp lain eosinophilia 
and increased plasma levels of IgE, which are present in advanced 
stages of CTCL. Moreover, decreased natural kill er celJ and 
Iymphokine-activated killer ce ll activity, as well as a decreased 
T-cell response to antigens and mitogens, have been described in 
advanced CTCL (Edelson , 1980). Interestin gly, Dummer cl nl 
(1993) have shown that peripheral blood m ononuclear cells in 
patients with non leukemic CTCL showed a prefe rential secretion 
of type 2 cytokines upon stimu lation (elevated secretio n oflL-4 and 
decreased secretion of IFN-y). In Sezary patients, similar results 
were found (Vowels cl ai, 1992), and IL- 12 produc tion was also 
found to be reduced (Rook cl ai, 1995) . T he question whether the 
overexpress ion of IL-l 0 induces tlus disturban ce of immune regu-
lation is of major importance, because this cOllld support filrther 
tumor progression , including extracutaneous manifestations, and 
may contribute to the increased ri sk of development of second 
m alignancy described in CTCL patients (Kantor cl ai, 1989) . 
This work has bel''' sup}Jorted by (/ grrllll./i'O/ lI tlte Delltsche ForscllllHgs CCl1l eill sc/wjt 
(Ste 366/6-1,6-2) . We thallk Dr. Allgela Si<:~li llg alld Dr. Floriall /(el"ll, Berlill , 
for critirn fly rendillg the IIIn"lIsrripf. 
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